Hardy Reed’s Bio-Techne TECH Stock Holding History

Hardy Reed’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,152	Closed	-$250K	–	111
2020 Q4	$250K	Sell	3,152 -920	-23%	-$66.6K	0.05%	88
2020 Q3	$252K	Hold	4,072	–	–	0.06%	75
2020 Q2	$269K	Buy	+4,072	New	+$244K	0.1%	61
2020 Q1	–	Sell	-4,072	Closed	-$223K	–	75
2019 Q4	$223K	Buy	+4,072	New	+$214K	0.08%	65
2019 Q3	–	Sell	-4,072	Closed	-$212K	–	70
2019 Q2	$212K	Hold	4,072	–	–	0.08%	64
2019 Q1	$202K	Buy	+4,072	New	+$183K	0.07%	63

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Hardy Reed's TECH Position: Q1 2021 in Review

Hardy Reed sold out of Bio-Techne (TECH) in Q1 2021, closing a stake of 3,152 shares — an estimated $250K sold.

Hardy Reed first reported a position in TECH in Q1 2019 and held it in 6 quarters. The position peaked at $269K in Q2 2020. 471 funds tracked by Wall St. Rank hold TECH as of Q1 2021.

Hardy Reed reported no remaining Bio-Techne position as of Q1 2021 after selling out during the quarter.
Hardy Reed sold 3,152 Bio-Techne shares in Q1 2021, an estimated $250K.
Hardy Reed first reported a position in Bio-Techne in Q1 2019 and held it in 6 quarters.
Hardy Reed's Bio-Techne position peaked at $269K in Q2 2020.
471 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2021.

Based on Hardy Reed's 13F filing for Q1 2021, filed 26 Apr 2021.